NL8204626A - Nieuwe verbinding met analgetische, ontstekingsremmende en muco-regulerende activiteit, de bereiding daarvan en verwante farmaceutische verbindingen. - Google Patents
Nieuwe verbinding met analgetische, ontstekingsremmende en muco-regulerende activiteit, de bereiding daarvan en verwante farmaceutische verbindingen. Download PDFInfo
- Publication number
- NL8204626A NL8204626A NL8204626A NL8204626A NL8204626A NL 8204626 A NL8204626 A NL 8204626A NL 8204626 A NL8204626 A NL 8204626A NL 8204626 A NL8204626 A NL 8204626A NL 8204626 A NL8204626 A NL 8204626A
- Authority
- NL
- Netherlands
- Prior art keywords
- afp
- ibuprofen
- activity
- muco
- inflammative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT20073/82A IT1190727B (it) | 1982-03-10 | 1982-03-10 | Composto ad attivita' analgesica,antiinfiammatoria e mucoregolatrice procedimento per la sua preparazione e relative composizioni farmaceutiche |
IT2007382 | 1982-03-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL8204626A true NL8204626A (nl) | 1983-10-03 |
Family
ID=11163583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8204626A NL8204626A (nl) | 1982-03-10 | 1982-11-29 | Nieuwe verbinding met analgetische, ontstekingsremmende en muco-regulerende activiteit, de bereiding daarvan en verwante farmaceutische verbindingen. |
Country Status (14)
Country | Link |
---|---|
US (1) | US4501914A (ja) |
JP (1) | JPS58162554A (ja) |
BE (1) | BE895111A (ja) |
CH (1) | CH650491A5 (ja) |
DE (1) | DE3242961C2 (ja) |
ES (1) | ES517685A0 (ja) |
FR (1) | FR2523124B1 (ja) |
GB (1) | GB2116541B (ja) |
GR (1) | GR77030B (ja) |
IT (1) | IT1190727B (ja) |
LU (1) | LU84486A1 (ja) |
NL (1) | NL8204626A (ja) |
PT (1) | PT75894B (ja) |
ZA (1) | ZA827898B (ja) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1212840B (it) * | 1983-11-28 | 1989-11-30 | Zambeletti Spa L | Derivati di acidi bifenililalcanoici, loro preparazione e composizioni farmaceutiche che licontengono. |
US9303038B2 (en) | 2011-09-06 | 2016-04-05 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological diseases |
US9399634B2 (en) | 2012-05-07 | 2016-07-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of depression |
JP2015519333A (ja) | 2012-05-07 | 2015-07-09 | セリックスビオ プライヴェート リミテッド | 神経疾患の治療のための組成物および方法 |
WO2013168021A1 (en) | 2012-05-07 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders |
US9266823B2 (en) | 2012-05-08 | 2016-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of parkinson's disease |
US9434704B2 (en) | 2012-05-08 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological degenerative disorders |
US20150133533A1 (en) * | 2012-05-08 | 2015-05-14 | Mahesh Kandula | Compositions and methods for the treatment of cough |
WO2013167991A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic disorders |
US9403826B2 (en) | 2012-05-08 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory disorders |
US9309233B2 (en) | 2012-05-08 | 2016-04-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of blood clotting disorders |
US9273061B2 (en) | 2012-05-10 | 2016-03-01 | Cellix Bio Private Limited | Compositions and methods for the treatment of chronic pain |
US9339484B2 (en) | 2012-05-10 | 2016-05-17 | Cellix Bio Private Limited | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
WO2013168016A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic syndrome |
US9242939B2 (en) | 2012-05-10 | 2016-01-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
WO2013167999A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurologic diseases |
US9321775B2 (en) | 2012-05-10 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of moderate to severe pain |
US9233161B2 (en) | 2012-05-10 | 2016-01-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological conditions |
WO2013167997A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic syndrome |
WO2013168014A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of familial amyloid polyneuropathy |
US9499526B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
WO2013168004A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of fibromyalgia pain |
US9573927B2 (en) | 2012-05-10 | 2017-02-21 | Cellix Bio Private Limited | Compositions and methods for the treatment of severe pain |
US9394288B2 (en) | 2012-05-10 | 2016-07-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of asthma and allergy |
CN104583182A (zh) | 2012-05-23 | 2015-04-29 | 塞利克斯比奥私人有限公司 | 用于治疗粘膜炎的组合物和方法 |
US9434729B2 (en) | 2012-05-23 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
CA2873096A1 (en) | 2012-05-23 | 2013-11-28 | Cellixbio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
WO2013175347A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of respiratory disorders |
US9492409B2 (en) | 2012-05-23 | 2016-11-15 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
CN104603097A (zh) | 2012-05-23 | 2015-05-06 | 塞利克斯比奥私人有限公司 | 用于治疗多发性硬化症的组合物和方法 |
US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
WO2014020480A2 (en) | 2012-08-03 | 2014-02-06 | Mahesh Kandula | Compositions and methods for the treatment migraine and neurologic diseases |
WO2014037833A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment inflammation and lipid disorders |
WO2014037834A2 (en) | 2012-09-08 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment of inflammation and lipid disorders |
US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
WO2014195961A1 (en) | 2013-06-04 | 2014-12-11 | Mahesh Kandula | Compositions and methods for the treatment of diabetes and pre-diabetes |
US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
CA2976314C (en) | 2014-09-26 | 2021-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological disorders |
ES2799309T3 (es) | 2014-09-29 | 2020-12-16 | Cellix Bio Private Ltd | Compuestos y composiciones para el tratamiento de esclerosis múltiple |
CA2965449C (en) | 2014-10-27 | 2020-11-10 | Cellix Bio Private Limited | Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis |
US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
CN107428697A (zh) | 2015-01-06 | 2017-12-01 | 塞尔利克斯生物私人有限公司 | 用于治疗炎症和疼痛的组合物和方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4150137A (en) * | 1975-12-24 | 1979-04-17 | Hisamitsu Pharmaceutical Co. Inc. | Pyridylalkyl esters of 2-(p-isobutylphenyl)acetic acid and propionic acids and use |
IT1064751B (it) * | 1976-07-09 | 1985-02-25 | Acraf | P. isobutil idratropato di guaiacolo |
-
1982
- 1982-03-10 IT IT20073/82A patent/IT1190727B/it active
- 1982-10-28 ZA ZA827898A patent/ZA827898B/xx unknown
- 1982-11-10 CH CH6536/82A patent/CH650491A5/it not_active IP Right Cessation
- 1982-11-12 US US06/441,106 patent/US4501914A/en not_active Expired - Fee Related
- 1982-11-20 DE DE3242961A patent/DE3242961C2/de not_active Expired
- 1982-11-23 GR GR69882A patent/GR77030B/el unknown
- 1982-11-24 BE BE2/59921A patent/BE895111A/nl not_active IP Right Cessation
- 1982-11-24 PT PT75894A patent/PT75894B/pt unknown
- 1982-11-24 FR FR8219679A patent/FR2523124B1/fr not_active Expired
- 1982-11-24 LU LU84486A patent/LU84486A1/xx unknown
- 1982-11-25 ES ES517685A patent/ES517685A0/es active Granted
- 1982-11-29 GB GB08233933A patent/GB2116541B/en not_active Expired
- 1982-11-29 NL NL8204626A patent/NL8204626A/nl not_active Application Discontinuation
- 1982-11-29 JP JP57210515A patent/JPS58162554A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
IT1190727B (it) | 1988-02-24 |
FR2523124B1 (fr) | 1985-07-19 |
IT8220073A0 (it) | 1982-03-10 |
JPH0121139B2 (ja) | 1989-04-19 |
PT75894B (en) | 1986-01-15 |
BE895111A (nl) | 1983-03-16 |
ES8401009A1 (es) | 1983-12-16 |
PT75894A (en) | 1982-12-01 |
DE3242961C2 (de) | 1984-05-10 |
ES517685A0 (es) | 1983-12-16 |
DE3242961A1 (de) | 1983-09-15 |
LU84486A1 (fr) | 1983-06-13 |
GB2116541A (en) | 1983-09-28 |
GR77030B (ja) | 1984-09-04 |
CH650491A5 (it) | 1985-07-31 |
US4501914A (en) | 1985-02-26 |
GB2116541B (en) | 1985-10-02 |
FR2523124A1 (fr) | 1983-09-16 |
JPS58162554A (ja) | 1983-09-27 |
ZA827898B (en) | 1983-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL8204626A (nl) | Nieuwe verbinding met analgetische, ontstekingsremmende en muco-regulerende activiteit, de bereiding daarvan en verwante farmaceutische verbindingen. | |
US4851426A (en) | Ethoxycarbonyloxy ethyl esters of non-steroidal anti-inflammatory carboxylic acids and pharmaceutical compositions thereof | |
KR100546038B1 (ko) | 항염증및항혈전성활성을지닌새로운화합물및그조성물 | |
RU2109009C1 (ru) | Производные 2-(2,6-дигалофениламино)фенилуксусной кислоты и способ их получения | |
JPH03500889A (ja) | キノリン誘導体 | |
PL188649B1 (pl) | Kompozycje farmaceutyczna do leczenia chorób, w których mediatorem jest cyklooksygenaza-2, zawierająca 3-fenylo-4-(4-(metylosulfonylo)fenylo)-2(5H)-furanon oraz zastosowanie 3-fenylo-4-(4-(metylosulfonylo)fenylo)-2(5H)-furanonu | |
EP0163270A2 (en) | A lipoxygenase inhibitor | |
CN111635309B (zh) | 一种新型解热镇痛药物及其制备方法和用途 | |
KR970011460B1 (ko) | 디-3급-부틸페놀 화합물의 사이클릭 유도체 및 이를 포함하는 약제학적 조성물 | |
JPS5946205B2 (ja) | ベンゾイル誘導体を有効成分とする消炎鎮痛剤 | |
US9351980B2 (en) | Di-aspirin derivatives | |
WO1987002891A1 (en) | Compounds and method for the topical treatment of inflammation and pain | |
JPH0222271A (ja) | 共役γ−オキシブテノライド化合物およびこれを有効成分とする抗潰瘍剤 | |
JPS58201713A (ja) | 製薬組成物およびその製造方法 | |
JPS631286B2 (ja) | ||
EP1505986A1 (en) | COMBINATION OF AN HMG-CoA REDUCTASE INHIBITOR AND A NITRATE ESTER | |
JPS6345678B2 (ja) | ||
US4000265A (en) | Method for treating arteriosclerotic and cardiovascular disorders | |
JPS6183125A (ja) | 癌転移阻害剤 | |
EP0091995A1 (en) | New compound having antiinflammatory, analgesic and mucoregulating activity, process for its production and relative pharmaceutical compositions | |
JPH02167227A (ja) | イソカルバサイクリン誘導体を活性成分として含有する糖尿病性神経症治療剤 | |
Singh et al. | Anti-inflammatory activity of some traditional medicinal plants | |
EP0440098A1 (en) | Optically active derivative of d-2-(6-methoxy-2-naphthyl)-propionic acid and pharmaceutical compositions containing it | |
SU869267A1 (ru) | N-[4-(3,3-Диметилтриазено)-фенилсульфонил]-изовалериламид, про вл ющий противовоспалительное действие | |
US3277166A (en) | Maleamic acid derviatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
BV | The patent application has lapsed |